BTF's 2023 Updates on Hematology and Oncology - Houston, TX

Houston, TX US
July 8, 2023 to July 9, 2023

This CME-accredited oncology conference, BTF's 2023 Updates on Hematology and Oncology, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.  

Expert faculty will provide a comprehensive overview of practice-changing abstracts presented at the 2023 ASCO® Annual Meeting (ASCO2023) in June 2023. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field. Expert faculty will place abstract findings from ASCO2023 into clinical contexts and discuss how the results may change the current standard of care.

Target Audience

  • Medical oncologists
  • Hematologist oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology residents/fellows
  • Oncology NPs/PAs
  • Oncology pharmacists
  • Oncology nurses

Hotel information

Attendee reservations must be received on or before 5:00 PM CST, Friday, June 16, 2023.  

BOOKING LINK - www.marriott.com/event-reservations

Learning Objectives

  1. Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
  2. Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
  3. Explain how to effectively manage side-effects associated with cancer treatment
  4. Review abstracts presented at ASCO® 2023 and discuss their application in clinical settings

 

Sponsorship acknowledgment

We thank the following Bronze Sponsors of this conference

.           

Course summary
Available credit: 
  • 11.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 11.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 11.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 11.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 11.00 Contact Hours.
Course opens: 
03/02/2023
Course expires: 
09/09/2023
Event starts: 
07/08/2023 - 8:00am PDT
Event ends: 
07/09/2023 - 12:15pm PDT
Cost:
$100.00
Add to calendar: 

Conference Co-Chairs: Dr. Vivek Subbiah & Dr. Siddhartha Ganguly

 

DAY 1 - July 8, 2023

All times below are listed in Central Time (CT).

07:00 – 08:00 AM: REGISTRATION, BREAKFAST, AND EXHIBITS

08:00 - 08:05 AM: Welcome - Siddhartha Ganguly, MD, FACP

08:05 - 08:15 AM: Binaytara Foundation's efforts in improving cancer care disparities - Binay Shah, MD

08:15 – 09:45 AM: HEMATOLOGIC MALIGNANCIES SESSION

Moderator: Siddhartha Ganguly, MD, FACP

08:15 - 08:45 AM: MDS/Leukemias - Martha Mims, MD, PhD

08:45 - 09:15 AM: Multiple Myeloma - Siddhartha Ganguly, MD, FACP

09:15 - 09:45 AM: Updates in Lymphoma - Paolo Strati, MD

09:45 – 10:30 AM: BREAK AND EXHIBITS IN ROOMS SALONS A - D

09:45 - 10:30: PRODUCT THEATER SPONSORED BY JANSSEN ONCOLOGY (CONFERENCE ROOM 1) 

“Frontline Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma Across Patient Types”

Speaker: Hamza Hashmi, MD

Assistant Professor, Division of Hematology/Oncology Medical

University of South Carolina

10:30 – 11:30 AM: THORACIC ONCOLOGY SESSION

Moderator: Bingnan Zhang, MD

10:30 - 11:00 AM: Updates in Lung Cancer - Eric Kumar Singhi, MD

11:00 - 11:30 AM: Updates in Metastatic Lung Cancer - Yasir Elamin, MD

11:30 - 12:15 PM: CASE-BASED PRESENTATIONS

Moderator: Sai Pingali, MD

11:30 - 11:40 AM: Lymphoma Case - Zimu Gong, MD

11:40 - 11:50 AM: Post CAR T Cytopenia Case - Siddhartha Ganguly, MD

11:50 - 12:00 PM: Case 3 - Abdul Rafeh Naqash, MD

12:00 - 12:15 PM: Case 4 - Tejo Musunuru, MD

12:15 – 13:15 PM: LUNCH AND EXHIBITS

12:30 - 13:15: PRODUCT THEATER SPONSORED BY EXELIXIS (CONFERENCE ROOM 1) 

“A Combination Treatment for Patients with Advanced Renal Cell Carcinoma”

Speaker: John Sarantopoulos, MD

Clinical Research Investigator and Medical Oncologist

University of Texas Health San Antonio MD Anderson Cancer Center

13:15 – 15:15 PM: GENERAL ONCOLOGY SESSION

Moderator: Garth Beinart, MD

13:15 - 13:45 PM: Sarcoma Updates - Neeta Somaiah, MD

13:45 - 14:15 PM: Brain Tumor Updates - Robert Rostomily, MD

14:15 - 14:45 PM: Gynecologic Cancer - Pedro Ramirez, MD

14:45 - 15:00 PM: A Case of GU Oncology - Mike Lattanzi, MD

15:00 - 15:15 PM: A Case of HLH - Shilpan Shah, MD

 

15:15 – 15:30: BREAK AND EXHIBITS

15:30 – 17:00 PM: GENITOURINARY CANCER SESSION

Moderator: Justin Lebenthal, MD

15:30 - 16:00 PM: Updates in Prostate Cancer - Ana Aparicio, MD

16:00 - 16:30 PM: Updates in Bladder Cancer - Omar Alhalabi, MD

16:30 - 17:00 PM: Updates in Kidney Cancer - Andrew Hahn, MD

 

DAY 2 - July 9, 2023

07:00 – 08:00 AM: REGISTRATION, BREAKFAST, AND EXHIBITS

08:00 – 08:30 AM: SKIN CANCER SESSION

08:00 - 08:30 AM: Melanoma Update - Rodabe Amaria, MD

08:30 - 09:00 AM - Case-Based Presentations:

Moderator: Siddhartha Ganguly, MD, FACP

08:30 - 08:40 AM: Case 1 - Deepak Bhamidipati, MD

08:40 - 08:50 AM: A case of Melanoma - Tara Davidson, MD

08:50 - 09:00 AM: A case of Breast Cancer - Akshjot Puri, MD

09:00 - 10:30 AM: GI CANCER SESSION

Moderator: Van Morris, MD

09:00 - 09:30 AM: Updates in Colorectal Cancer - Madhulika Eluri, MD

09:30 - 10:00 AM: Updates in Hepatobiliary Cancer - Milind Javle, MD

10:00 - 10:30 AM: Upper GI Cancer - Anirudha Dasgupta, MD, FACP

10:30 - 10:45 AM: BREAK AND EXHIBITS

10:45 - 12:15 PM: BREAST CANCER SESSION

Moderator: Banu K Arun, MD

10:45 - 11:15 AM: ER+ Breast Cancers - Darya A Kizub, MD

11:15 - 11:45 AM: HER2+ Breast Cancer -  Bora Lim, MD

11:45 - 12:15 PM: Triple-Negative Breast Cancer - Kai Sun, MD, MS

12:15 PM: ADJOURN

Houston Marriott Medical Center/Museum District
6580 Fannin Street
Houston, TX 77030-2708
United States

Reservations must be received on or before 5:00 PM CST, Friday, June 16, 2023, (the “Cut-Off Date”).  

BOOKING LINK - https://www.marriott.com/event-reservations/reservation-link.mi?id=1675962142120&key=GRP&app=resvlink

 

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Akshjot Puri, MD has no relevant financial relationships to disclose at this time.

Course Director(s)

Siddhartha Ganguly, MD, FACP

has a financial relationship (Financial Support) with Kite Pharma;.
has a financial relationship (Financial Support) with Astra Zeneca;.
has a financial relationship (Financial Support) with Sanofi Genzyme;.

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Speaker/Topic Presenter(s)

Omar Alhalabi, MD

has a financial relationship (Grant Or Contract) with Arcus;.
has a financial relationship (Other) with Silverback;.
has a financial relationship (Grant Or Contract) with AstraZeneca;.
has a financial relationship (Other) with Seagen;.
has a financial relationship (Grant Or Contract) with Genentech;.
has a financial relationship (Grant Or Contract) with Ikena;.
has a financial relationship (Other) with Cardinal health;.

Roda Amaria, MD, Associate Professor

has a financial relationship (Professional Services) with Iovance;.
has a financial relationship (Grant Or Contract) with Obsidian;.
has a financial relationship (Grant Or Contract) with Roche;.
has a financial relationship (Grant Or Contract) with OnKure;.
has a financial relationship (Professional Services) with Erasca;.

Ana Aparicio

has a financial relationship (Professional Services) with Sanofi Genzyme;.
has a financial relationship (Professional Services) with Janssen Biotech, Inc.;.
has a financial relationship (Professional Services) with Bristol-Myers Squibb;.

Deepak Bhamidipati

has no relevant financial relationships to disclose at this time.

Anirudha Dasgupta, MD FACP

has no relevant financial relationships to disclose at this time.

Tara Davidson, M.D.

has no relevant financial relationships to disclose at this time.

Yasir Elamin, MD

has a financial relationship (Professional Services) with BMS;.
has a financial relationship (Professional Services) with AstraZeneca;.
has a financial relationship (Professional Services) with Takeda;.

Madhulika Eluri, MD

has no relevant financial relationships to disclose at this time.

Siddhartha Ganguly, MD, FACP

has a financial relationship (Financial Support) with Sanofi Genzyme;.
has a financial relationship (Financial Support) with Kite Pharma;.
has a financial relationship (Financial Support) with Astra Zeneca;.

Zimu Gong, MD, PhD

has no relevant financial relationships to disclose at this time.

Andrew Hahn, MD

has a financial relationship (Professional Services) with Intellisphere;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Travel) with Dava Oncology;.

Milind Javle, MD

has a financial relationship (Grant Or Contract) with Astra Zeneca, Merck, Helsinn, Transthera, Taiho, BMS, Servier ;.
has a financial relationship (Grant Or Contract) with Incyte;.

Darya Kizub, MD

has no relevant financial relationships to disclose at this time.

Michael Lattanzi

has a financial relationship (Professional Services) with Aadi;.
has a financial relationship (Financial Support) with Aveo;.
has a financial relationship (Professional Services) with Merck;.
has a financial relationship (Financial Support) with Seagen;.
has a financial relationship (Financial Support) with EMD Serono;.
has a financial relationship (Professional Services) with Aveo;.
has a financial relationship (Financial Support) with Janssen;.
has a financial relationship (Professional Services) with Janssen;.
has a financial relationship (Financial Support) with Astrazeneca;.

Bora Lim, M.D.

has a financial relationship (Professional Services) with Gilead;.

Martha Mims

has a financial relationship (Grant Or Contract) with Celgene;.
has a financial relationship (Stock) with Biogen IDEC;.
has a financial relationship (Stock) with Amgen;.
has a financial relationship (Grant Or Contract) with Incyte;.
has a financial relationship (Grant Or Contract) with Aveo;.

Tejo Musunuru, MD

has no relevant financial relationships to disclose at this time.

Abdul Rafeh Naqash, MD

has no relevant financial relationships to disclose at this time.

Pedro Ramirez, MD, FACOG

has no relevant financial relationships to disclose at this time.

Robert Rostomily

has no relevant financial relationships to disclose at this time.

Shilpan Shah

has no relevant financial relationships to disclose at this time.

Eric Singhi, Eric K. Singhi, MD

has no relevant financial relationships to disclose at this time.

Paolo Strati, MD

has a financial relationship (Professional Services) with Kite-Gilead;.
has a financial relationship (Professional Services) with Astrazeneca;.
has a financial relationship (Professional Services) with Roche Genentech;.
has a financial relationship (Professional Services) with ADC Therapeutics;.

Kai Sun, M.D.

has no relevant financial relationships to disclose at this time.
Moderator(s)

Banu Arun

has a financial relationship (Other) with Astra Zeneca;.

Garth Beinart, MD

has no relevant financial relationships to disclose at this time.

Deepak Bhamidipati

has no relevant financial relationships to disclose at this time.

Tara Davidson, M.D.

has no relevant financial relationships to disclose at this time.

Justin Lebenthal

has no relevant financial relationships to disclose at this time.

Van Morris, MD

has a financial relationship (Grant Or Contract) with Novartis;.
has a financial relationship (Independent contractor) with Incyte;.
has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Grant Or Contract) with Bicara;.
has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Grant Or Contract) with EMD Serono;.
has a financial relationship (Grant Or Contract) with BioNTech;.
has a financial relationship (Independent contractor) with Regeneron;.

Sai Ravi Pingali

has a financial relationship (Professional Services) with Cardinal Health;.

Bingnan Zhang

has no relevant financial relationships to disclose at this time.
Planning committee(s)

Darya Kizub, MD

has no relevant financial relationships to disclose at this time.

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

This activity is supported with an independent medical education grant from the following companies:

  • Seagen
  • Astrazeneca

Available Credit

  • 11.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 11.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 11.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 11.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 11.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$100.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education occurs. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot, or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company can attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.